https://lucyrx.com/wp-content/uploads/2026/09/Employer-benefits-leader-evaluating-specialty-pharmacy-performance.png
536
800
Kyrstin Hensley
/wp-content/uploads/2025/03/LucyRx-Logo-Primary.svg
Kyrstin Hensley2026-09-21 08:00:232026-09-15 13:55:18How Should a Specialty Pharmacy Earn Its Role?Guides & Toolkits

Six employer-tested PBM strategies for controlling pharmacy cost, improving transparency, and delivering better member outcomes in 2026.
GLP-1 growth, specialty drug spend, and opaque PBM practices are forcing employers to rethink how pharmacy is governed, not just how it is priced.
6 for 2026 shares six real employer and member scenarios that show how organizations are managing:
- GLP-1 utilization and cost exposure
- Specialty drug growth
- Biosimilar adoption
- Women’s health and menopause care
- PBM transparency and accountability
Each scenario highlights the challenge, the strategy shift, and the impact on cost, access, and member experience, so you can quickly see what actually works in today’s pharmacy landscape.
Want a clearer view of your pharmacy benefit?
LucyRx works with employers, brokers, and consultants to apply these prescription care strategies to real pharmacy data, helping leaders understand where cost, access, and outcomes are aligned, and where they are not.
Recommended Reads
https://lucyrx.com/wp-content/uploads/2026/09/Employer-benefits-leader-evaluating-specialty-pharmacy-performance.png
536
800
Kyrstin Hensley
/wp-content/uploads/2025/03/LucyRx-Logo-Primary.svg
Kyrstin Hensley2026-09-21 08:00:232026-09-15 13:55:18How Should a Specialty Pharmacy Earn Its Role?
Projected Savings vs. Realized Savings: What Employers Should Ask
Employers need to know whether a pharmacy savings figure represents an opportunity or an actual result. This article explains how to evaluate savings methodology, assumptions, and outcomes.

A Better Way to Think About GLP-1 Strategy
GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.

Diabetes Affordability is About More Than One Prescription
Diabetes affordability extends beyond insulin. Learn how employers can evaluate medication costs, GLP-1s, monitoring devices, coverage rules, and member support across the full diabetes regimen.

Is Your Pharmacy Benefit Still Working as Intended?
A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.

Disclosure Won. Now What?
PBM transparency gives employers greater visibility into pharmacy costs—but disclosure is only the beginning. Learn how plan sponsors can turn better information into greater control, accountability, and measurable results.

The Human Side of Pharmacy Savings
Savings matter. The person behind each case matters more. How LucyRx Care Guides delivered $2.37 million in savings by starting with one simple thing: listening.

Pharmacy Savings Shouldn’t Come at the Employee’s Expense
Pharmacy savings shouldn't come at the employee's expense. See how one large hospitality and entertainment employer reduced net pharmacy spend by 15% in year one while lowering member PMPM from $16.10 to $9.52, through focused GLP-1 management, Care Guide support, and a smart biosimilar strategy.

Women’s Heart Health Belongs in the Benefits Conversation
Benefit conversations still tend to treat menopause, heart health, weight, diabetes, pharmacy coverage, and care navigation as separate issues. They are not separate for the woman trying to navigate them.

The CFO Case for Care Guides: From Cost Pressure to Controllable Results
Care Guides lower specialty spend and improve adherence. Discover how employers can reduce PMPM costs and gain measurable ROI.

How Should a Specialty Pharmacy Earn Its Role?
Specialty pharmacy can materially affect employer plan costs, access, and treatment continuity. This article outlines the measures benefits leaders can use to evaluate pharmacy channels based on evidence rather than affiliation.

Projected Savings vs. Realized Savings: What Employers Should Ask
Employers need to know whether a pharmacy savings figure represents an opportunity or an actual result. This article explains how to evaluate savings methodology, assumptions, and outcomes.

A Better Way to Think About GLP-1 Strategy
GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.

Diabetes Affordability is About More Than One Prescription
Diabetes affordability extends beyond insulin. Learn how employers can evaluate medication costs, GLP-1s, monitoring devices, coverage rules, and member support across the full diabetes regimen.

Is Your Pharmacy Benefit Still Working as Intended?
A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.

Disclosure Won. Now What?
PBM transparency gives employers greater visibility into pharmacy costs—but disclosure is only the beginning. Learn how plan sponsors can turn better information into greater control, accountability, and measurable results.

The Human Side of Pharmacy Savings
Savings matter. The person behind each case matters more. How LucyRx Care Guides delivered $2.37 million in savings by starting with one simple thing: listening.

Pharmacy Savings Shouldn’t Come at the Employee’s Expense
Pharmacy savings shouldn't come at the employee's expense. See how one large hospitality and entertainment employer reduced net pharmacy spend by 15% in year one while lowering member PMPM from $16.10 to $9.52, through focused GLP-1 management, Care Guide support, and a smart biosimilar strategy.

Women’s Heart Health Belongs in the Benefits Conversation
Benefit conversations still tend to treat menopause, heart health, weight, diabetes, pharmacy coverage, and care navigation as separate issues. They are not separate for the woman trying to navigate them.

Share